• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞动脉炎对患者生活有何影响?一项英国的定性研究。

What is the impact of giant cell arteritis on patients' lives? A UK qualitative study.

作者信息

Liddle Jennifer, Bartlam Roisin, Mallen Christian D, Mackie Sarah L, Prior James A, Helliwell Toby, Richardson Jane C

机构信息

Research Institute for Primary Care and Health Sciences, Keele University, Keele, UK.

Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.

出版信息

BMJ Open. 2017 Aug 23;7(8):e017073. doi: 10.1136/bmjopen-2017-017073.

DOI:10.1136/bmjopen-2017-017073
PMID:28838902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5724062/
Abstract

OBJECTIVES

Clinical management of giant cell arteritis (GCA) involves balancing the risks and burdens arising from the disease with those arising from treatment, but there is little research on the nature of those burdens. We aimed to explore the impact of giant cell arteritis (GCA) and its treatment on patients' lives.

METHODS

UK patients with GCA participated in semi-structured telephone interviews. Inductive thematic analysis was employed.

RESULTS

24 participants were recruited (age: 65-92 years, time since diagnosis: 2 months to >6 years). The overarching themes from analysis were: ongoing symptoms of the disease and its treatment; and 'life-changing' impacts. The overall impact of GCA on patients' lives arose from a changing combination of symptoms, side effects, adaptations to everyday life and impacts on sense of normality. Important factors contributing to loss of normality were glucocorticoid-related treatment burdens and fear about possible future loss of vision.

CONCLUSIONS

The impact of GCA in patients' everyday lives can be substantial, multifaceted and ongoing despite apparent control of disease activity. The findings of this study will help doctors better understand patient priorities, legitimise patients' experiences of GCA and work with patients to set realistic treatment goals and plan adaptations to their everyday lives.

摘要

目的

巨细胞动脉炎(GCA)的临床管理涉及平衡疾病产生的风险和负担与治疗产生的风险和负担,但对于这些负担的性质研究甚少。我们旨在探讨巨细胞动脉炎(GCA)及其治疗对患者生活的影响。

方法

英国的GCA患者参与了半结构化电话访谈。采用归纳主题分析法。

结果

招募了24名参与者(年龄:65 - 92岁,诊断后时间:2个月至6年以上)。分析得出的总体主题为:疾病及其治疗的持续症状;以及“改变生活”的影响。GCA对患者生活的总体影响源于症状、副作用、对日常生活的适应以及对正常感的影响等多种因素的不断变化组合。导致失去正常感的重要因素是糖皮质激素相关的治疗负担以及对未来可能失明的恐惧。

结论

尽管疾病活动看似得到控制,但GCA对患者日常生活的影响可能很大、多方面且持续存在。本研究结果将有助于医生更好地理解患者的优先事项,使患者对GCA的经历合理化,并与患者共同设定现实的治疗目标以及规划对其日常生活的调整。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68fd/5724062/5ba50e87c4c7/bmjopen-2017-017073f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68fd/5724062/5ba50e87c4c7/bmjopen-2017-017073f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68fd/5724062/5ba50e87c4c7/bmjopen-2017-017073f01.jpg

相似文献

1
What is the impact of giant cell arteritis on patients' lives? A UK qualitative study.巨细胞动脉炎对患者生活有何影响?一项英国的定性研究。
BMJ Open. 2017 Aug 23;7(8):e017073. doi: 10.1136/bmjopen-2017-017073.
2
Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.巨细胞动脉炎患者健康相关生活质量的感知:一种疾病特异性患者报告结局测量方法的国际制定。
Rheumatology (Oxford). 2021 Oct 2;60(10):4671-4680. doi: 10.1093/rheumatology/keab076.
3
Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study.全科医疗中巨细胞动脉炎的诊断与管理挑战:一项多方法研究
BMJ Open. 2018 Feb 3;8(2):e019320. doi: 10.1136/bmjopen-2017-019320.
4
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.巨细胞动脉炎合并抗中性粒细胞胞质抗体相关性血管炎:一项病例对照研究。
Arthritis Rheumatol. 2021 Feb;73(2):286-294. doi: 10.1002/art.41527. Epub 2020 Dec 21.
5
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.大剂量糖皮质激素治疗 3 天可减轻大动脉型巨细胞动脉炎患者 18F-FDG 摄取,但对诊断准确性的影响有限。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1119-1128. doi: 10.1007/s00259-018-4021-4. Epub 2018 Apr 18.
6
Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.巨细胞动脉炎表现出代谢组学改变,这些改变进一步被糖皮质激素治疗所改变:疲劳代谢相关性的鉴定。
J Autoimmun. 2024 Jul;147:103260. doi: 10.1016/j.jaut.2024.103260. Epub 2024 May 25.
7
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.临床特征和糖皮质激素对巨细胞动脉炎活检结果的影响。
BMC Musculoskelet Disord. 2016 Aug 24;17(1):363. doi: 10.1186/s12891-016-1225-2.
8
Visual prognosis in giant cell arteritis.
Ophthalmology. 1993 Apr;100(4):550-5. doi: 10.1016/s0161-6420(93)31608-8.
9
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.巨细胞动脉炎(GCA)患者糖皮质激素治疗相关的严重不良反应:一项巢式病例对照分析。
Semin Arthritis Rheum. 2017 Jun;46(6):819-827. doi: 10.1016/j.semarthrit.2016.11.006. Epub 2016 Nov 28.
10
Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.是否存在糖皮质激素抵抗性大血管血管炎(巨细胞动脉炎和 Takayasu 动脉炎),如何实现缓解?文献综述。
Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S114-29. Epub 2012 May 11.

引用本文的文献

1
Illness Burden and Unmet Patient Needs in Giant Cell Arteritis: Current State and Future Prospects.巨细胞动脉炎的疾病负担与未满足的患者需求:现状与未来展望
Open Access Rheumatol. 2025 Jul 1;17:117-134. doi: 10.2147/OARRR.S517664. eCollection 2025.
2
Social determinants of health influence patients' access to care for vasculitis.健康的社会决定因素影响患者获得血管炎治疗的机会。
Clin Rheumatol. 2024 Dec;43(12):4027-4028. doi: 10.1007/s10067-024-07217-7. Epub 2024 Oct 30.
3
Anxiety and depression in patients with giant cell arteritis.

本文引用的文献

1
Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.大血管血管炎疗效评估指标发展的最新情况:OMERACT 12报告
J Rheumatol. 2015 Dec;42(12):2465-9. doi: 10.3899/jrheum.141144. Epub 2015 Jun 15.
2
"I suddenly felt I'd aged": a qualitative study of patient experiences of polymyalgia rheumatica (PMR).“我突然觉得自己变老了”:一项关于风湿性多肌痛(PMR)患者经历的定性研究。
Patient Educ Couns. 2015 May;98(5):645-50. doi: 10.1016/j.pec.2014.12.013. Epub 2015 Jan 15.
3
Perceptions of recovery and prognosis from long-term conditions: The relevance of hope and imagined futures.
巨细胞动脉炎患者的焦虑和抑郁
Rheumatol Adv Pract. 2024 Jan 30;8(1):rkae013. doi: 10.1093/rap/rkae013. eCollection 2024.
4
Fatigue: It Is Not Always in the Head.疲劳:并非总是源于心理。
Cureus. 2023 Jun 4;15(6):e39959. doi: 10.7759/cureus.39959. eCollection 2023 Jun.
5
Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis.患者报告的结果为巨细胞动脉炎中抑郁症状增加和精神损害加重提供了证据。
Front Med (Lausanne). 2023 May 12;10:1146815. doi: 10.3389/fmed.2023.1146815. eCollection 2023.
6
Comment on: Benchmarking tocilizumab use for giant cell arteritis.关于“托珠单抗治疗巨细胞动脉炎的基准评估”的评论
Rheumatol Adv Pract. 2022 Aug 23;6(3):rkac069. doi: 10.1093/rap/rkac069. eCollection 2022.
7
Impact of Giant Cell Arteritis and Its Treatment on the Patient's Quality of Life: A Single-Center Self-Assessment Study.巨细胞动脉炎及其治疗对患者生活质量的影响:一项单中心自我评估研究。
Front Med (Lausanne). 2021 Nov 10;8:777310. doi: 10.3389/fmed.2021.777310. eCollection 2021.
8
Patterns of attendances to the hospital emergency eye care service: a multicentre study in England.医院急诊眼科护理服务的就诊模式:英格兰的一项多中心研究。
Eye (Lond). 2022 Dec;36(12):2304-2311. doi: 10.1038/s41433-021-01849-8. Epub 2021 Nov 30.
9
Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.巨细胞动脉炎患者健康相关生活质量的感知:一种疾病特异性患者报告结局测量方法的国际制定。
Rheumatology (Oxford). 2021 Oct 2;60(10):4671-4680. doi: 10.1093/rheumatology/keab076.
10
Patient Reported Outcomes in Large Vessel Vasculitides.大血管血管炎患者报告的结局。
Curr Rheumatol Rep. 2021 Jan 28;23(2):7. doi: 10.1007/s11926-020-00979-4.
对慢性病康复及预后的认知:希望与想象中未来的相关性。
Chronic Illn. 2015 Mar;11(1):3-20. doi: 10.1177/1742395314534275. Epub 2014 May 7.
4
BSR and BHPR guidelines for the management of giant cell arteritis.英国风湿病学会(BSR)和英国卫生与保健优化研究所(BHPR)巨细胞动脉炎管理指南
Rheumatology (Oxford). 2010 Aug;49(8):1594-7. doi: 10.1093/rheumatology/keq039a. Epub 2010 Apr 5.
5
Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.视力障碍对生活质量的影响:与普通人群的生活质量及其他慢性病状况的比较。
Ophthalmic Epidemiol. 2007 May-Jun;14(3):119-26. doi: 10.1080/09286580601139212.
6
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.1990 - 2001年英国确诊的风湿性多肌痛和颞动脉炎发病率。
Ann Rheum Dis. 2006 Aug;65(8):1093-8. doi: 10.1136/ard.2005.046912. Epub 2006 Jan 13.
7
The fight for 'health-related normality': a qualitative study of the experiences of individuals living with established inflammatory bowel disease (ibd).为“与健康相关的正常状态”而战:对患有确诊炎症性肠病(IBD)个体经历的定性研究
J Health Psychol. 2005 May;10(3):443-55. doi: 10.1177/1359105305051433.
8
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.基于意大利人群的巨细胞动脉炎患者队列中视力丧失的危险因素。
Arthritis Rheum. 2005 Apr 15;53(2):293-7. doi: 10.1002/art.21075.
9
Domains of health-related quality of life important to patients with giant cell arteritis.对巨细胞动脉炎患者而言重要的健康相关生活质量领域。
Arthritis Rheum. 2003 Dec 15;49(6):819-25. doi: 10.1002/art.11464.
10
Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.巨细胞动脉炎的糖皮质激素治疗:疗程与不良结局
Arthritis Rheum. 2003 Oct 15;49(5):703-8. doi: 10.1002/art.11388.